US FDA Approves Granules’ Blood Pressure Tablets
Granules India announced that its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg, received approval from the US Food and Drug Administration (FDA). Losartan Potassium is a bioequivalent to the reference recorded drug item (RLD), Cozaar Tablets of Organon LLC. The US Food and Drug Administration […]
Continue Reading